Evidence supporting the use of: Mixed carotenoids
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Mixed carotenoids, which include compounds such as beta-carotene, lutein, zeaxanthin, and others, have attracted interest for their potential role in supporting eye health, including conditions like diabetic retinopathy. The scientific rationale centers on the antioxidant properties of carotenoids, which can help neutralize oxidative stress—a known contributor to the progression of diabetic retinopathy. Some observational studies and small clinical trials have indicated that higher dietary intake or supplementation with carotenoids, particularly lutein and zeaxanthin, may be associated with improved retinal function or reduced progression of diabetic retinopathy in people with diabetes. However, the overall evidence level remains modest.

Notably, a few clinical studies have shown that supplementation with these carotenoids can improve macular pigment optical density and visual function in diabetic patients, suggesting a potential protective effect against the oxidative and inflammatory damage characteristic of diabetic retinopathy. Despite these findings, large-scale, high-quality randomized controlled trials specifically targeting diabetic retinopathy outcomes are lacking. Most evidence is extrapolated from general studies on eye health or from preclinical research.

Therefore, while there is a reasonable scientific hypothesis and some supportive data for the use of mixed carotenoids in diabetic retinopathy, the strength of evidence is currently limited (rated 2/5), and more robust clinical research is needed to make definitive recommendations. Mixed carotenoids are not a standard treatment but may be considered as adjunctive nutritional support.

More about mixed carotenoids
More about Diabetic Retinopathy